[EN] RAD51 INHIBITORS<br/>[FR] INHIBITEURS DE RAD51
申请人:CYTEIR THERAPEUTICS INC
公开号:WO2020186006A1
公开(公告)日:2020-09-17
This application is directed to inhibitors of RAD51 represented by the following structural formula, (I), and methods for their use, such as to treat cancer, autoimmune diseases, immune deficiencies, or neurodegenerative diseases.
Substituted Pyrrololactams via Ring Expansion of Spiro-2<i>H</i>-pyrroles from Intermolecular Alkyne–Isocyanide Click Reactions
作者:Jimil George、Hun Young Kim、Kyungsoo Oh
DOI:10.1021/acs.orglett.6b03786
日期:2017.2.3
The facile synthesis of 6- to 8-membered pyrrololactams has been developed using a ringexpansion of spiro-2H-pyrroles, the products of intermolecular alkyne–isocyanide click reactions. The key to successful ringexpansion of spiro-2H-pyrroles to pyrrololactams is the enforced orbital overlap between the internal alkene and the amide carbonyl group through the conformationally locked bicyclic structures
[EN] AMIDE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS<br/>[FR] DÉRIVÉS D'AMIDE D'INHIBITEURS DE L'AMIDASE ACIDE DE N-ACYLÉTHANOLAMINE À BASE DE LACTAME
申请人:UNIV CALIFORNIA
公开号:WO2014144547A2
公开(公告)日:2014-09-18
Described herein are compounds and pharmaceutical compositions which inhibit N-acylethanolamine acid amidase (NAAA). Described herein are methods for synthesizing the compounds set forth herein and methods for formulating these compounds as pharmaceutical compositions which include these compounds. Also described herein are methods of inhibiting NAAA in order to sustain the levels of palmitoylethanolamide (PEA) and other N-acylethanolamines (NAE) that are substrates for NAAA, in conditions characterized by reduced concentrations of NAE. Also, described here are methods of treating and ameliorating pain, inflammation, inflammatory diseases, and other disorders in which modulation of fatty acid ethanolamides is clinically or therapeutically relevant or in which decreased levels of NAE are associated with the disorder.
Synthesis of .beta.-lactam antibiotics by the sulfeno-cycloamination